Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report)’s share price traded down 0.3% on Tuesday . The stock traded as low as $2.7745 and last traded at $2.8520. 17,735 shares were traded during mid-day trading, an increase of 55% from the average daily volume of 11,449 shares. The stock had previously closed at $2.8610.
Medexus Pharmaceuticals Stock Performance
The business’s 50-day simple moving average is $2.88 and its two-hundred day simple moving average is $2.41.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Featured Articles
- Five stocks we like better than Medexus Pharmaceuticals
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
